Quick Links

beta cells Tag

For people age 12 – 35 years who have been diagnosed with type 1 diabetes in the past 3 months, this study tests two JAK inhibitors (abrocitinib and ritlecitinib) to see if either or both can preserve insulin production. TrialNet researchers are testing two different JAK...

For adults age 18 – 45 years who have been diagnosed with type 1 diabetes in the past 18 months, the DESIGNATE study will test whether a new drug called siplizumab will reduce or block the T-cells that attack the insulin-producing beta cells. The goal of...

SITE PARTNERS
uw-footer